Mushroom edibles are becoming increasingly popular in the U.S., offering various mind-altering experiences, from mild boosts in focus to psychedelic trips. However, many of these products do not contain psilocybin, the chemical found in magic mushrooms, but instead are made with Amanita muscaria, which contains muscimol, a hallucinogenic compound. The lack of regulation in these products raises concerns about ingredient accuracy and safety.
An increase in reports of illnesses linked to mushroom edibles, such as those from the company Prophet Premium Blends, has prompted recalls and investigations by the FDA and CDC. Symptoms reported by affected individuals include seizures, loss of consciousness, confusion, and abnormal heart rates, with some products found to have higher than normal levels of muscimol or other compounds like psilacetin that can have mind-altering effects.
Despite the growing popularity of mushroom edibles, experts are calling for increased regulation to ensure product safety and accuracy. Poison control centers are seeing a rise in cases related to these products, with concerns about potential health risks, especially related to seizures.
While some suggest educating consumers and setting minimal regulatory standards as potential solutions, the lack of standardized testing and quality control remains a challenge. The true health risks associated with mushroom edibles, particularly those made with Amanita muscaria, are difficult to quantify without proper lab testing. In the meantime, caution is advised when consuming these products, and consumers are encouraged to carefully examine lab analyses and ingredient lists for transparency and safety.
Photo credit
www.nbcnews.com
